Skip to main content

Advertisement

SpringerLink
Log in

Neuropsychiatric Disorders in Dementia: Mechanisms of Development and Approaches to Correction

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Dementia is often combined with other mental disorders which can manifest at different stages of the disease. The severity and rate of progression of these disorders may depend on the nosological nature of the disease producing the dementia, as well as environmental factors, concomitant diseases, etc. Each psychopathological syndrome is linked with a characteristic neurotransmitter imbalance and selective involvement of different parts of the CNS in the pathological process. Treatment must be selected individually taking account of the balance of benefits and the risks of prescribed medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. E. E. Vasenina and O. S. Levin, “Features of the clinical picture and treatment of moderate and severe Alzheimer’s disease,” Zh. Nevrol. Psikhiat., 115, No. 6, Iss. 2, 17–25 (2015), https://doi.org/10.17116/jnevro20151156217-25.

    Article  CAS  Google Scholar 

  2. O. S. Levin and E. E. Vasenina, “25 years of the amyloid hypothesis of the origin of Alzheimer’s disease: successes, failure, and new perspectives,” Zh. Nevrol. Psikhiat., 116, No. 6, Iss. 2, 3–12 (2016), https://doi.org/10.17116/jnevro2016116623-9.

    Article  CAS  Google Scholar 

  3. D. A. Gutorova, E. E. Vasenina, and O. S. Levin, “Screening for cognitive disorders in the elderly and aged using the 3-CT scale,” Zh. Nevrol. Psikhiat., 116, No. 6, Iss. 2, 35–42 (2016), https://doi.org/10.17116/jnevro20161166235-40.

    Article  CAS  Google Scholar 

  4. U. Preuss, J. Wong, and G. Koller, “Treatment of behavioral and psychological symptoms of dementia: a systematic review,” Psychiatr. Polska, 50, No. 4, 679–715 (2016), https://doi.org/10.12740/pp/64477.

    Article  Google Scholar 

  5. P. Aalten, M. de Vugt, N. Jaspers, et al., “The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables,” Int. J. Geriatr. Psychiatry, 20, No. 6, 531–536 (2005), https://doi.org/10.1002/gps.1317.

    Article  PubMed  Google Scholar 

  6. C. Fox, M. Crugel, I. Maidment, et al., “Efficacy of memantine for agitation in Alzheimer’s dementia: a randomised double-blind placebo-controlled trial,” PLoS One, 7, No. 5, 35185 (2012), https://doi.org/10.1371/journal.pone.0035185.

    Article  CAS  Google Scholar 

  7. X. Li, N. Hu, M. Tan, et al., “Behavioral and psychological symptoms in Alzheimer’s disease,” BioMed Res. Int., 1–9 (2014), https://doi.org/10.1155/2014/927804.

  8. L. Zahodne, K. Ornstein, S. Cosentino, et al., “Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, agitation/aggression,” Am. J. Clin. Geriatr. Psychiatry, 23, No. 2, 130–140 (2015), https://doi.org/10.1016/j.jagp.2013.3.014.

    Article  Google Scholar 

  9. P. Robert, G. Berrut, S. Bonin-Guillaume, et al., “Estime study: Apathy and depression in mild and newly diagnosed Alzheimer disease,” Alz. Dement., 7, No. 4, 362–363 (2011), https://doi.org/10.1016/j.jalz.2011.05.1045.

    Article  Google Scholar 

  10. Y. Kwak, Y. Yang, S. Pyo, and M. Koo, “Clinical characteristics according to depression screening tools in patients with Alzheimer’s disease: View from self, caregiver-reported and drug-intervention pattern,” Getriatr. Gerontol. Int., 14, No. 3, 660–666 (2013), https://doi.org/10.1111/ggi.12154.

    Article  Google Scholar 

  11. H. Lenoir, C. Dufouil, S. Auriacombe, et al., “Depression history, depressive symptoms and incident dementia: The 3C study,” Alz. Dement., 7, No. 4, 355–356 (2011), https://doi.org/10.1016/j.jalz.2011.05.1029.

    Article  Google Scholar 

  12. C. Holmes, M. Arranz, D. Collier, et al., “Depression in Alzheimer’s disease: The effect of serotonin receptor gene variation,” Am. J. Med. Genet., 119B, No. 1, 40–43 (2003), https://doi.org/10.1002/ajmg.b.10068.

    Article  PubMed  Google Scholar 

  13. A. Pritchard, C. Pritchard, P. Bentham, and C. Lendon, “Role of serotonin transporter polymorphisms in the behavioural and psychological symptoms in probable Alzheimer disease patients,” Dement. Geriatr. Cogn. Disord., 24, No. 3, 201–206 (2007), https://doi.org/10.1159/000107081.

    Article  CAS  PubMed  Google Scholar 

  14. I. Blasko, G. Kemmler, S. Jungwirth, et al., “Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease,” Am. J. Clin. Geriatr. Psychiatry, 18, No. 11, 973–982 (2010), https://doi.org/10.1097/jgp.0b013e3181df48be.

    Article  Google Scholar 

  15. J. Kang, J. Lee, H. Kang, et al., “Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer’s disease,” Alzheimer Dis. Assoc. Disord., 26, No. 3, 217–224 (2012), https://doi.org/10.1097/wad.0b013e318231e5fc.

    Article  PubMed  Google Scholar 

  16. A. Lebedev, M. Beyer, F. Fritze, et al., “Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: An MRI surface-based morphometric study,” Am. J. Clin. Geriatr. Psychiatry, 22, No. 1, 4–13 (2014), https://doi.org/10.1016/j.jagp.2013.02.004.

    Article  Google Scholar 

  17. J. Brommelhoff, B. Spann, J. Go, et al., “Striatal hypodensities, not white matter hypodensities, are associated with late-onset depression in Alzheimer’s disease,” J. Aging Res., 1–11 (2011), https://doi.org/10.4061/2011/187219.

  18. L. Bidzan, M. Bidzan, and M. Pąchalska, “Aggressive and impulsive behavior in Alzheimer’s disease and progression of dementia,” Med. Sci. Monit., 18, No. 3, 182–189 (2012), https://doi.org/10.12659/msm.882523.

    Article  Google Scholar 

  19. K. Lanctôt, “Central serotonergic activity is related to the aggressive behaviors of Alzheimer’s disease,” Neuropsychopharmacology, (2012), https://doi.org/10.1016/s0893-133x(02)00339-1.

  20. R. Sweet, V. Nimgaonkar, M. Kamboh, et al., “Dopamine receptor genetic variation, psychosis, aggression in Alzheimer’s disease,” Arch. Neurol., 55, No. 10, 1335 (1998), https://doi.org/10.1001/archneur.55.10.1335.

    Article  CAS  PubMed  Google Scholar 

  21. K. Matthews, C. Chen, M. Esiri, et al., “Noradrenergic changes, aggressive behavior, cognition in patients with dementia,” Biol. Psychiatry, 51, No. 5, 407–416 (2002), https://doi.org/10.1016/s0006-3223(01)01235-5.

    Article  CAS  PubMed  Google Scholar 

  22. S. Guadagna, M. Esiri, R. Williams, and P. Francis, “Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia,” Neurobiol. Aging, 33, No. 12, 2798–2806 (2012), https://doi.org/10.1016/j.neurobiolaging.2012.01.015.

    Article  CAS  PubMed  Google Scholar 

  23. P. Trzepacz, P. Yu, P. Bhamidipati, B. Willis, et al., “Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease,” Alz. Dement., 9, No. 5, 95–104 (2013), https://doi.org/10.1016/j.jalz.2012.10.005.

    Article  Google Scholar 

  24. F. Esposito, L. Rochat, A. Van der Linden, et al., “Apathy and executive dysfunction in Alzheimer’s disease,” Alzheimer Dis. Assoc. Disord., 24, No. 2, 131–137 (2010), https://doi.org/10.1097/wad.0b013e3181c9c168.

    Article  PubMed  Google Scholar 

  25. T. Mori, H. Shimada, H. Shinotoh, et al., “Apathy correlates with prefrontal amyloid deposition in Alzheimer’s disease,” J. Neurol. Neurosurg. Psychiatry, 85, No. 4, 449–455 (2013), https://doi.org/10.1136/jnnp-2013-306110.

    Article  PubMed  Google Scholar 

  26. N. Donovan, L. Wadsworth, N. Lorius, et al., “Regional cortical thinning predicts worsening apathy and hallucinations in mild cognitive impairment and mild Alzheimer’s disease dementia,” Alz. Dement., 8, No. 4, 342–343 (2012), https://doi.org/10.1016/j.jalz.2012.05.943.

    Article  Google Scholar 

  27. C. Lee, C. Hahn, and W. Won, “Apathy and white matter in Alzheimer’s disease: A whole-brain analysis with tract-based spatial statistics,” Alz. Dement., 9, No. 4, 373–374 (2013), https://doi.org/10.1016/j.jalz.2013.05.728.

    Article  Google Scholar 

  28. D. Gilley, J. Bienias, R. Wilson, et al., “Infl uence of behavioral symptoms on rates of institutionalization for persons with Alzheimer’s disease,” Psychol. Med., 34, No. 6, 1129–1135 (2004), https://doi.org/10.1017/s0033291703001831.

    Article  CAS  PubMed  Google Scholar 

  29. B. Creese, C. Ballard, and E. Jones, “Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer’s disease: a systematic review,” Dement. Geriatr. Cogn. Disord., 35, No. 3–4, 155–164 (2013), https://doi.org/10.1159/000346733.

    Article  CAS  PubMed  Google Scholar 

  30. N. Ertekin-Taner, “Alzheimer’s disease: The quest for Alzheimer disease genes – focus on CSF tau,” Nat. Rev. Neurol., 9, No. 7, 368–370 (2013), https://doi.org/10.1038/nrneurol.2013.117.

    Article  CAS  PubMed  Google Scholar 

  31. J. Koppel, S. Sunday, T. Goldberg, et al., “Psychosis in Alzheimer’s disease is associated with frontal metabolic impairment and accelerated decline in working memory: fi ndings from the Alzheimer’s disease neuroimaging initiative,” Am. J. Clin. Geriatr. Psychiatry, 22, No. 7, 698–707 (2014), https://doi.org/10.1016/j.jagp.2012.10.028.

    Article  Google Scholar 

  32. M. Rafii, C. Taylor, H. Kim, et al., “Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer’s disease,” Am. J. Alzheimers Dis. Other Dement., 29, No. 2, 159–165 (2014), https://doi.org/10.1177/1533317513507373.

    Article  Google Scholar 

  33. K. Nomura, H. Kazui, T. Wada, et al., “Classifi cation of delusions in Alzheimer’s disease and their neural correlates,” Psychogeriatrics, 12, No. 3, 200–210 (2012), https://doi.org/10.1111/j.1479-8301.2012.00427.x.

  34. H. Kales, L. Gitlin, and C. Lyketsos, “Assessment and management of behavioral and psychological symptoms of dementia,” BMJ, 350, 369 (2015), https://doi.org/10.1136/bmj.h369.

    Article  Google Scholar 

  35. N. Hodgson, L. Gitlin, L. Winter, and K. Czekanski, “Undiagnosed illness and neuropsychiatric behaviors in community residing older adults with dementia,” Alzheimer Dis. Assoc. Disord., 25, No. 2, 109–115 (2011), https://doi.org/10.1097/wad.0b013e3181f8520a.

    Article  PubMed  PubMed Central  Google Scholar 

  36. B. Husebo, C. Ballard, J. Cohen-Mansfield, et al., “The response of agitated behavior to pain management in persons with dementia,” Am. J. Clin. Geriatr. Psychiatry, 22, No. 7, 708–717 (2014), https://doi.org/10.1016/j.jagp.2012.12.006.

    Article  Google Scholar 

  37. L. Clare, B. Wilson, G. Carter, et al., “Depression and anxiety in memory clinic attenders and their carers: implications for evaluating the effectiveness of cognitive rehabilitation interventions,” Int. J. Geriatr. Psychiatry, 17, No. 10, 962–967 (2002), https://doi.org/10.1002/gps.735.

    Article  PubMed  Google Scholar 

  38. C. Cooper, T. Balamurali, A. Selwood, and G. Livingston, “A systematic review of intervention studies about anxiety in caregivers of people with dementia,” Int. J. Geriatr. Psychiatry, 22, No. 3, 181–188 (2007), https://doi.org/10.1002/gps.1656.

    Article  PubMed  Google Scholar 

  39. C. Lyketsos, L. DelCampo, M. Steinberg, et al., “Treating depression in Alzheimer disease,” Arch. Gen. Psychiatry, 60, No. 7, 737 (2003), https://doi.org/10.1001/archpsyc.60.7.737.

    Article  CAS  PubMed  Google Scholar 

  40. P. Rabins, “Backed-up against the wall: Pharmacology to assuage the PAADS (psychosis, apathy, agitation, depression, sleep problems) clusters in dementia,” Alz. Dement., 9, No. 4, 2 (2013), https://doi.org/10.1016/j.jalz.2013.04.510.

    Article  Google Scholar 

  41. L. Drye, D. Spragg, D. Devanand, et al., “Changes in QTc interval in the Citalopram for Agitation in Alzheimer’s Disease (CitAD) randomized trial,” PLoS One, 9, No. 6, 98426 (2014), https://doi.org/10.1371/journal.pone.0098426.

    Article  Google Scholar 

  42. M. Apreda, F. Cano, C. Foces-Foces, et al., “ChemInform abstract: crystal and molecular structure of the alimemazine cation radical,” ChemInform, 18, No. 35, (1997), https://doi.org/10.1002/chin.198735057.

  43. “Alimemazine increases night-time sleep,” InPharma, 586, No. 1, 8–8 (1987), https://doi.org/10.1007/bf03305903.

  44. “Alimemazine surpasses diazepam as paediatric premedication,” InPharma, 592, No. 1, 8–8 (1987), https://doi.org/10.1007/bf03291381.

  45. K. Georgeson, “Effectiveness of alimemazine in controlling retching after Nissen fundoplication,” Yearbook Surg., 235–236 (2007), https://doi.org/10.1016/s0090-3671(08)70180-0.

Download references

Author information

Authors and Affiliations

  1. Russian Medical Academy of Continuing Professional Education, Moscow, Russia

    E. E. Vasenina & O. A. Gan’kina

Authors
  1. E. E. Vasenina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. A. Gan’kina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. E. Vasenina.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 117, No. 6, Iss. II, Neurology and Psychiatry in the Elderly, pp. 58–65, June, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vasenina, E.E., Gan’kina, O.A. Neuropsychiatric Disorders in Dementia: Mechanisms of Development and Approaches to Correction. Neurosci Behav Physi 49, 434–440 (2019). https://doi.org/10.1007/s11055-019-00751-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-019-00751-x

Keywords

Search

Navigation